Targeting the DNA Damage Response in OSCC with TP53 Mutations

A Lindemann, H Takahashi, AA Patel… - Journal of dental …, 2018 - journals.sagepub.com
Oral squamous cell carcinoma (OSCC) is the most common type of oral cancer worldwide
and in the United States. OSCC remains a major cause of morbidity and mortality in patients …

Drugs targeting epigenetic modifications and plausible therapeutic strategies against colorectal cancer

S Patnaik, Anupriya - Frontiers in Pharmacology, 2019 - frontiersin.org
Genetic variations along with epigenetic modifications of DNA are involved in colorectal
cancer (CRC) development and progression. CRC is the fourth leading cause of cancer …

Hdac1 and Hdac2 act redundantly to control p63 and p53 functions in epidermal progenitor cells

M LeBoeuf, A Terrell, S Trivedi, S Sinha, JA Epstein… - Developmental cell, 2010 - cell.com
Epidermal and hair follicle development from surface ectodermal progenitor cells requires
coordinated changes in gene expression. Histone deacetylases alter gene expression …

New tricks from an old oncogene: Gene fusion and copy number alterations of MYB in human cancer

G Stenman, MK Andersson, Y Andrén - Cell Cycle, 2010 - Taylor & Francis
MYB is a leucine zipper transcription factor that is essential for hematopoesis and for
renewal of colonic crypts. There is also ample evidence showing that MYB is leukemogenic …

Expression of aquaporin 5 increases proliferation and metastasis potential of lung cancer

Z Zhang, Z Chen, Y Song, P Zhang… - The Journal of …, 2010 - Wiley Online Library
Abstract Water channel aquaporin 5 (AQP5) is highly expressed at the apical membrane of
alveolar type I epithelial cells and confers high osmotic water permeability. AQP5 is also …

Current paradigms in epigenetic anticancer therapeutics and future challenges

M Singh, V Kumar, N Sehrawat, M Yadav… - Seminars in Cancer …, 2022 - Elsevier
Any alteration at the genetic or epigenetic level, may result in multiplex of diseases including
tumorigenesis which ultimately results in the cancer development. Restoration of the normal …

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and …

F Bruzzese, A Leone, M Rocco… - Journal of cellular …, 2011 - Wiley Online Library
Potentiation of epidermal growth factor receptor (EGFR) inhibitors is required in squamous
cell carcinoma of head and neck (SCCHN) to improve their therapeutic index. We …

[HTML][HTML] Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling

A Heinemann, C Cullinane, R De Paoli-Iseppi… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Histone acetylation marks have an important role in controlling gene expression and are
removed by histone deacetylases (HDACs). These marks are read by bromodomain and …

Novel medicinal mushroom blend suppresses growth and invasiveness of human breast cancer cells

J Jiang, D Sliva - International journal of oncology, 2010 - spandidos-publications.com
Mushrooms are an integral part of Traditional Chinese Medicine (TCM), and have been
used for millennia to prevent or treat a variety of diseases. Currently mushrooms or their …

Survivin-based treatment strategies for squamous cell carcinoma

A Santarelli, M Mascitti, L Lo Russo, D Sartini… - International journal of …, 2018 - mdpi.com
Survivin, an anti-apoptotic molecule abundantly expressed in most human neoplasms, has
been reported to contribute to cancer initiation and drug resistance in a wide variety of …